Narrowband TL-01 phototherapy for patch-stage mycosis fungoides

Archives of Dermatology

Volumn 136, Issue 6, 2000, Pages 748-752

  Clark, Colin ^a,b   Dawe, Robert S ^a   Evans, Alan T ^a   Lowe, Graham ^a   Ferguson, James ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MYCOSIS FUNGOIDES; PHOTOTHERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR REGRESSION; ULTRAVIOLET B RADIATION;

EID: 0034051268     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.136.6.748     Document Type: Article

References (31)

1. Kaye FJ, Burn PA Jr, Steinberg SM, et al. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med. 1989;321:1784-1790.
2. Holloway KB, Flowers FP, Ramos-Caro FA. Theraputic alternatives in cutaneous T-cell lymphoma. J Am Acad Dermatol. 1992; 27:367-378.
3. Herrmann JJ, Roenigk HH, Hurria A, et al. Treatment of mycosis fungoides with phototherapy (PUVA): long-term follow-up. J Am Acad Dermatol. 1995;33:234-242.
4. Ramsey DL, Lish KM, Yalowitz CB, Soter NA. Ultraviolet-B phototherapy for early-stage cutaneous T-cell lymphoma. Arch Dermatol. 1992;128:931-933.
5. Van Weelden H, Baart de la Faille H, Young E, Van der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol. 1988;119:11-19.
6. Green C, Ferguson J, Lakshmipathi T, Jonhnson BE. 311-nm UVB phototherapy: an effective treatment for psoriasis. Br J Dermatol. 1988;119:691-696.
7. Picot E, Meunier L, Picot-Debeze MC, Peyron JL, Meynadier J. Treatment of pscriasis with a 311-nm UVB lamp. Br J Dermatol. 1992;127:509-512.
8. Coven T, Burack LH, Gilleaudeau P, Keogh M, Ozawa M, Krueger J. Narrowband UV-B produces clinical and histological resolution of moderate to severe psoriasis in patients compared with broadband UV-B. Arch Dermatol. 1997;133:1514-1522.
9. Hofer A, Cerroni L, Kerl H, Wolf P. Narrowband (311-nm) UV-B therapy for small plaque parapsoriasis and early stage mycosis fungoides. Arch Dermatol. 1999; 135:1377-1380.
10. Sanchez JI, Ackerman AB. The patch stage of mycosis fungoides: criteria for histological diagnosis. Am J Dermatopathol. 1979;1:5-26.
11. Bunn PA, Lamberg SI. Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas. Cancer Treat Rep. 1979;63:725-728.
12. Kim YH, Jensen RA, Watanabe GL, Varghese A, Hoppe R. Clinical stage IA (limited patch and plaque) mycosis fungoides: a long-term outcome analysis Arch Dermatol. 1996;132:1309-1313.
13. Wainwright NJ, Dawe RS, Ferguson J. Narrow-band UVB (TL-01) phototherapy for psoriasis: which incremental regimen? Br J Dermatol. 1998;139:410-414.
14. Madhu AP, Fitzpatrick TB. Preventative treatment of sunburn, dermatoheliosis, and skin cancer with sun-protective agents. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in General Medicine 4th ed. New York, NY: McGraw-Hill; 1993:1689-1717.
15. Tore JR, Stoll HL, Stomper PC, Oseroff AR. Prognostic factors and evaluation of mycosis fungoides and Sézary syndrome. J Am Acad Dermatol. 1997;37:58-67.
16. Kim YH, Chow S, Varghese A, Hoppe R. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. Arch Dermatol. 1999;135:26-32.
17. Bluefarb SM. Cutaneous Manifestations of the Malignant Lymphomas. Springfield, III: Charles C. Thomas Publisher; 1959:173.
18. Milstein HJ, Vonderheid EC, Van Scott EJ, Johnson WC. Home ulraviolet phototherapy of early mycosis fungoides: preliminary observations. J Am Acad Dermatol. 1982;6:355-362.
19. Resnick KS, Vonderheid EC. Home UV phototherapy of early mycosis fungoides. J Am Acad Dermatol. 1993;29:73-77.
20. Piccinno R, Caccialanza M, Mainardi L. Confront tra l risultati ottenuti co radiazione ultravioletta e con fotochemioterapia negli stadi iniziali della micosi fungoide. G Ital Dermatol Venereol. 1990;125:91-95.
21. MacKie RM, Foulds IS, McMillan EM, Nelson H. Histological changes observed in the skin of patients with mycosis fungoides receiving photochemotherapy. Clin Exp Dermatol. 1980;5:405-413.
22. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis: photochemotherapy follow-up study. Cancer. 1994;73:2759-2764.
23. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA): the PUVA follow-up study. N Engl J Med. 1997;336:1041-1045.
24. Vonderheid EC, Tan ET, Kantor AF, Shrager L, Micaily B, Van Scott EJ. Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T-cell lymphoma. J Am Acad Dermatol. 1989;20:416-428.
25. Zackheim HS, Epstein EH Jr, Grain WR. Topical carmustine (BCNU) for cutaneous T-cell lymphoma. J Am Acad Dermatol. 1990;22:802-810.
26. Hoppe RT, Fuks Z, Bagshaw MA. Radiation therapy in the management of cutaneous T-cell lymphomas. Cancer Treat Rep. 1979;63:625-632.
27. De Gruijl FR. Long-term side effects and carcinogenesis risk in UVB therapy. In: Honigsmann H, Jori G, Young AR, eds. The Fundamental Bases of Phototherapy. Milan, Italy: OEMF spa; 1996:153-170.
28. Young A. Carcinogenicity of UVB phototherapy assessed. Lancet. 1995;345: 1431-1432.
29. McGregor JM, Crook T, Fraser-Andrews EA, Rozycka M, Crossland S, Brooks L, et al. Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas. J Invest Dermatol. 1999;112:317-321.
30. Whitmore AS, Holly EA, Lee IM, et al. Mycosis fungoides in relation to environmental exposure and immune response. J Nat Cancer Inst 1989;81:1560-1567.
31. Tuyp E, Burgoyne A, Aitcheson T, MacKie R. A case control study of possible causative factors in mycosis fungoides. Arch Dermatol. 1987;123:196-200.